COMPASS Pathways (CMPS) Common Equity (2019 - 2026)
COMPASS Pathways' Common Equity was $84.53 million in Q2 2026, down 48.0% from $162.56 million a year earlier and down 74.1% from the prior quarter.
Powered by 
Analysis
COMPASS Pathways (CMPS) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at COMPASS Pathways came in at -$52.85 million.
- In earlier years, Common Equity was $154.7 million in FY2024 (-31.5%), $225.74 million in FY2023 (+24.5%), $181.28 million in FY2022 (-36.3%) and $284.41 million in FY2021 (+44.7%).
- Quarterly Common Equity has moved between -$52.85 million (Q4 2025) and $326.69 million (Q1 2026) over five years.
- Compared with a year earlier, Common Equity was higher in 1 of the last seven quarters, with an average decline of 24.2%.
- The best year-over-year quarter for Common Equity over five years was Q1 2026 (growth of 67.1%); the worst was Q3 2025 (a decline of 80.5%).
- Per Business Quant data, CMPS's Common Equity in the three quarters before Q2 2026 was $326.69 million (Q1 2026), -$52.85 million (Q4 2025) and $37.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | COMPASS Pathways | 1.80 Bn | 1.80 Bn | - | 84.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 84.53 Mn |
| Mar 31, 2026 | 326.69 Mn |
| Dec 31, 2025 | -52.85 Mn |
| Sep 30, 2025 | 37.59 Mn |
| Jun 30, 2025 | 162.56 Mn |
| Mar 31, 2025 | 195.47 Mn |
| Dec 31, 2024 | 154.70 Mn |
| Sep 30, 2024 | 193.03 Mn |
| Jun 30, 2024 | 226.27 Mn |
| Mar 31, 2024 | 259.16 Mn |
| Dec 31, 2023 | 225.74 Mn |
| Sep 30, 2023 | 253.26 Mn |
| Jun 30, 2023 | 166.40 Mn |
| Mar 31, 2023 | 161.64 Mn |
| Dec 31, 2022 | 181.28 Mn |
| Sep 30, 2022 | 194.56 Mn |
| Jun 30, 2022 | 224.59 Mn |
| Mar 31, 2022 | 259.57 Mn |
| Dec 31, 2021 | 284.41 Mn |
| Sep 30, 2021 | 305.42 Mn |
API Access
COMPASS Pathways Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CMPS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CMPS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CMPS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();